Association between AT1 and AT2 angiotensin II receptor expression with cell proliferation and angiogenesis in operable breast cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association between AT1 and AT2 angiotensin II receptor expression with cell proliferation and angiogenesis in operable breast cancer
Authors
Keywords
ATI, ATII, Angiotensin II, Breast cancer, Angiogenesis, AT1 blockers
Journal
TUMOR BIOLOGY
Volume 36, Issue 7, Pages 5627-5634
Publisher
Springer Nature
Online
2015-02-17
DOI
10.1007/s13277-015-3235-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ang II-AT1R Increases Cell Migration Through PI3K/AKT and NF-κB Pathways in Breast Cancer
- (2014) Yanbin Zhao et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Use of ACE Inhibitors and Angiotensin Receptor Blockers and Primary Breast Cancer Outcomes
- (2013) Young Kwang Chae et al. Journal of Cancer
- Angiotensin II type 1 receptor antagonists inhibit cell proliferation and angiogenesis in breast cancer
- (2012) Xuesong Chen et al. CANCER LETTERS
- Angiotensin II Type 1 Receptor (AT-1R) Expression Correlates with VEGF-A and VEGF-D Expression in Invasive Ductal Breast Cancer
- (2012) Aleksandra Jethon et al. PATHOLOGY & ONCOLOGY RESEARCH
- Angiotensin II Facilitates Breast Cancer Cell Migration and Metastasis
- (2012) Sylvie Rodrigues-Ferreira et al. PLoS One
- Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort
- (2011) Patricia A. Ganz et al. BREAST CANCER RESEARCH AND TREATMENT
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cancer progression and survival: a systematic review
- (2011) Úna C. Mc Menamin et al. CANCER CAUSES & CONTROL
- Reduced Risk of Breast Cancer Recurrence in Patients Using ACE Inhibitors, ARBs, and/or Statins
- (2011) Young Kwang Chae et al. CANCER INVESTIGATION
- The renin–angiotensin system in the breast and breast cancer
- (2011) Gavin P Vinson et al. ENDOCRINE-RELATED CANCER
- Common cardiovascular medications in cancer therapeutics
- (2011) Christos Vaklavas et al. PHARMACOLOGY & THERAPEUTICS
- AGTR1 overexpression defines a subset of breast cancer and confers sensitivity to losartan, an AGTR1 antagonist
- (2009) D. R. Rhodes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Expression of AT1 and AT2 angiotensin receptors in astrocytomas is associated with poor prognosis
- (2008) O Arrieta et al. BRITISH JOURNAL OF CANCER
- The renin-angiotensin system and malignancy
- (2008) E. I. Ager et al. CARCINOGENESIS
- Overcoming Recurrence Risk: Extended Adjuvant Endocrine Therapy
- (2008) Mary Cianfrocca Clinical Breast Cancer
- Anti-cancer actions of a recombinant antibody (R6313/G2) against the angiotensin II AT1 receptor
- (2008) M A Redondo-Muller et al. ENDOCRINE-RELATED CANCER
- Potential role of Renin–Angiotensin-system for tumor angiogenesis in receptor negative breast cancer
- (2008) D. Herr et al. GYNECOLOGIC ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation